{"id":3140,"date":"2023-12-02T09:42:37","date_gmt":"2023-12-02T02:42:37","guid":{"rendered":"https:\/\/hva.group\/?p=3140"},"modified":"2024-08-26T16:24:29","modified_gmt":"2024-08-26T09:24:29","slug":"wall-street-research-goes-after-amgens-strategic-changes","status":"publish","type":"post","link":"https:\/\/hva.group\/en\/wall-street-research-goes-after-amgens-strategic-changes\/","title":{"rendered":"Pro Research: Wall Street Digs Into Amgen's Strategic Shifts"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n

Amid the rapidly evolving biopharmaceutical landscape, Amgen Inc. (NASDAQ: AMGN) has captured Wall Street\u2019s attention with its robust pipeline, strategic acquisitions, and innovative therapeutics. Analysts are closely monitoring Amgen\u2019s progress, offering a variety of views on the company\u2019s financial health, stock performance, and future prospects. This in-depth analysis incorporates the latest insights from industry experts, providing a comprehensive look at Amgen\u2019s market position, product segments, competitive landscape, and more.<\/p>\n\n\n\n

Company Overview<\/h2>\n\n\n\n

Amgen, a pioneer in the biotechnology industry, is known for its commitment to addressing unmet medical needs through innovative research and drug development. With a diverse portfolio spanning oncology, cardiovascular disease, bone health, neuroscience, kidney and inflammation, the company has made significant strides in improving patient outcomes. Amgen\u2019s strategic focus includes advancing its oncology pipeline, with key assets such as Blincyto, tarlatamab, xaluritamig and precision oncology taking center stage.<\/p>\n\n\n\n

Performance and market strategy<\/h2>\n\n\n\n

Analysts have noted Amgen\u2019s outperformance in recent months, with a 17% gain over the three-month period, demonstrating resilience in an unpredictable market. The company\u2019s strategy of returning approximately 60% of non-GAAP net income to shareholders through dividends and share buybacks through 2030 reflects a strong commitment to delivering value. Furthermore, Amgen\u2019s recent acquisition of Horizon Pharma has bolstered its portfolio, with the integration of Horizon\u2019s assets expected to contribute significantly to Amgen\u2019s revenue stream.<\/p>\n\n\n\n

Product and pipeline segmentation<\/h2>\n\n\n\n

Amgen\u2019s product segments are marked by notable developments, particularly in oncology. The company is actively engaging with the FDA and has seen positive clinical trial results for its PRMT5-targeted lung cancer treatments. Tarlatamab, part of Amgen\u2019s BiTE platform, is advancing to Phase 3 trials, and the company\u2019s investments in dermatology and expansion of its primary care sales force are poised to enhance top-line growth. Additionally, biosimilar approvals and upcoming launches of biosimilar versions of Soliris and Eylea present growth opportunities.<\/p>\n\n\n\n

Competitive landscape<\/h2>\n\n\n\n

The competitive landscape for Amgen includes challenges and opportunities. While the company faces competition in its Inflammation & Immunology (I&I) franchise, it also sees demand for alternative therapies in markets such as prostate cancer. Amgen\u2019s diverse oncology portfolio and new mechanisms of action for pipeline assets such as AMG-193 could drive market enthusiasm. However, competition from other companies with similar drug programs and the potential for competitor drugs with better safety profiles could impact Amgen\u2019s market share and sales.<\/p>\n\n\n\n

Legal environment and external factors<\/h2>\n\n\n\n

Amgen\u2019s engagement with regulatory agencies like the FDA is an important aspect of its operations. The company is currently in discussions with the FDA about tarlatamab and has incorporated feedback into its clinical development strategies. External factors, including macroeconomic conditions and healthcare industry trends, also play a role in shaping Amgen\u2019s trajectory.<\/p>\n\n\n\n

Financial health and analysis goals<\/h2>\n\n\n\n

Financially, Amgen has shown strength, with management raising its 2023 guidance for both revenue and earnings. The company\u2019s Q3 2023 earnings report demonstrated resilience in its underlying business, and Amgen\u2019s adjusted revenue and EPS were positive despite challenges with new product launches. Analysts have reflected this financial strength in their price targets and ratings, although opinions vary.<\/p>\n\n\n\n

Bear case<\/h2>\n\n\n\n

Is Amgen Overvalued in the Current Market?<\/h3>\n\n\n\n

Some analysts have expressed concerns about Amgen\u2019s valuation, arguing that the stock may be overvalued relative to its growth prospects. The lower rating and lower price target imply a cautious stance on the company\u2019s near-term potential, with specific concerns about competitive pressures and the outcome of the transfer pricing case with the IRS.<\/p>\n\n\n\n

What risks could affect Amgen's stock performance?<\/h3>\n\n\n\n

Risks to Amgen\u2019s stock performance include potential underperformance in key product segments, uncertainty around its product pipeline, and competitive threats. The downside outlook is also affected by the company\u2019s dependence on clinical trial results and regulatory approvals, which can be unpredictable and have a significant impact on investor sentiment.<\/p>\n\n\n\n

The case of cows<\/h2>\n\n\n\n

What growth opportunities can investors anticipate from Amgen?<\/h3>\n\n\n\n

Investors can expect growth opportunities stemming from Amgen\u2019s strong commercial execution, pipeline assets with upside potential, and strategic acquisitions. The bull case is supported by rising revenue guidance, strong sales force investment, and the positive impact of biosimilar launches on the market.<\/p>\n\n\n\n

How does Amgen's strategic approach benefit shareholders?<\/h3>\n\n\n\n

Amgen\u2019s strategic approach, which includes a commitment to delivering shareholder returns and a focus on expanding its product portfolio through R&D investments and acquisitions, positions the company for sustainable growth. The optimism is further reinforced by the company\u2019s financial strength and operational execution, which are expected to drive revenue growth and enhance shareholder value.<\/p>\n\n\n\n

SWOT Analysis<\/h2>\n\n\n\n

Strengths:<\/p>\n\n\n\n

\u2013 Diverse product portfolio, focusing strongly on cancer.<\/p>\n\n\n\n

\u2013 Strategic acquisitions drive clinical progress and revenue.<\/p>\n\n\n\n

\u2013 Strong pipeline with potential in key therapeutic areas.<\/p>\n\n\n\n

Weaknesses:<\/p>\n\n\n\n

\u2013 Competitive pressure in I&I franchising.<\/p>\n\n\n\n

\u2013 Poor performance of new product launches.<\/p>\n\n\n\n

\u2013 Concerns about valuation and legal risks.<\/p>\n\n\n\n

Opportunity:<\/p>\n\n\n\n

\u2013 Growth in biosimilar market and upcoming product launches.<\/p>\n\n\n\n

\u2013 Expand into new treatment areas and markets.<\/p>\n\n\n\n

\u2013 Positive clinical trial results and FDA approval.<\/p>\n\n\n\n

Threat:<\/p>\n\n\n\n

\u2013 Potential adverse outcomes in clinical trials.<\/p>\n\n\n\n

\u2013 Strong competition from other biopharmaceutical companies.<\/p>\n\n\n\n

\u2013 Macroeconomic factors affecting health care spending and drug prices.<\/p>\n\n\n\n

Analysts' goals<\/h2>\n\n\n\n

\u2013 Research firm Argus maintains a BUY rating with a price target of $280 (September 18, 2023).<\/p>\n\n\n\n

\u2013 Barclays Capital Inc. maintains an Underweight rating with a price target of $ 230.00 (November 1, 2023).<\/p>\n\n\n\n

\u2013 Truist Securities upgrades to BUY rating and sets price target at $320 (November 2, 2023).<\/p>\n\n\n\n

\u2013 BMO Capital Markets assigned a Market Perform rating with a price target of $ 286.00 (Oct 25, 2023).<\/p>\n\n\n\n

\u2013 RBC Capital Markets maintains a Sector Perform rating with a price target of $ 256.00 (November 1, 2023).<\/p>\n\n\n\n

This analysis runs from September to November 2023.<\/p>","protected":false},"excerpt":{"rendered":"

Amidst the rapidly developing biopharmaceutical landscape, Amgen Inc. (NASDAQ: AMGN) has captured Wall Street's attention with its robust pipeline, strategic acquisitions, and innovative therapies. Analysts are closely monitoring Amgen's progress, providing [\u2026]<\/p>","protected":false},"author":9,"featured_media":3141,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"chi\u1ebfn l\u01b0\u1ee3c","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"Trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m sinh h\u1ecdc ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, Amgen Inc. (NASDAQ: AMGN) \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a Ph\u1ed1 Wall v\u1edbi \u0111\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd, mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 ph\u01b0\u01a1ng ph\u00e1p tr\u1ecb li\u1ec7u s\u00e1ng t\u1ea1o. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111ang theo d\u00f5i ch\u1eb7t ch\u1ebd ti\u1ebfn tr\u00ecnh c\u1ee7a Amgen, \u0111\u01b0a ra nhi\u1ec1u quan \u0111i\u1ec3m kh\u00e1c nhau v\u1ec1 s\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh, hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu v\u00e0 tri\u1ec3n v\u1ecdng t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ty. Ph\u00e2n t\u00edch chuy\u00ean s\u00e2u n\u00e0y h\u1ee3p nh\u1ea5t nh\u1eefng hi\u1ec3u bi\u1ebft m\u1edbi nh\u1ea5t t\u1eeb c\u00e1c chuy\u00ean gia trong ng\u00e0nh, cung c\u1ea5p c\u00e1i nh\u00ecn to\u00e0n di\u1ec7n v\u1ec1 v\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng, ph\u00e2n kh\u00fac s\u1ea3n ph\u1ea9m, b\u1ed1i c\u1ea3nh c\u1ea1nh tranh c\u1ee7a Amgen v\u00e0 h\u01a1n th\u1ebf n\u1eefa.","footnotes":""},"categories":[28],"tags":[16,15],"class_list":["post-3140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tin-tuc-thi-truong","tag-kinh-te","tag-tai-chinh"],"acf":[],"yoast_head":"\nNghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen - HVA Group<\/title>\n<meta name=\"description\" content=\"Trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m sinh h\u1ecdc ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, Amgen Inc. (NASDAQ: AMGN) \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a Ph\u1ed1 Wall v\u1edbi \u0111\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd, mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 ph\u01b0\u01a1ng ph\u00e1p tr\u1ecb li\u1ec7u s\u00e1ng t\u1ea1o. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111ang theo d\u00f5i ch\u1eb7t ch\u1ebd ti\u1ebfn tr\u00ecnh c\u1ee7a Amgen, \u0111\u01b0a ra nhi\u1ec1u quan \u0111i\u1ec3m kh\u00e1c nhau v\u1ec1 s\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh, hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu v\u00e0 tri\u1ec3n v\u1ecdng t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ty. Ph\u00e2n t\u00edch chuy\u00ean s\u00e2u n\u00e0y h\u1ee3p nh\u1ea5t nh\u1eefng hi\u1ec3u bi\u1ebft m\u1edbi nh\u1ea5t t\u1eeb c\u00e1c chuy\u00ean gia trong ng\u00e0nh, cung c\u1ea5p c\u00e1i nh\u00ecn to\u00e0n di\u1ec7n v\u1ec1 v\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng, ph\u00e2n kh\u00fac s\u1ea3n ph\u1ea9m, b\u1ed1i c\u1ea3nh c\u1ea1nh tranh c\u1ee7a Amgen v\u00e0 h\u01a1n th\u1ebf n\u1eefa.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/posts\/3140\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen\" \/>\n<meta property=\"og:description\" content=\"Trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m sinh h\u1ecdc ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, Amgen Inc. (NASDAQ: AMGN) \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a Ph\u1ed1 Wall v\u1edbi \u0111\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd, mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 ph\u01b0\u01a1ng ph\u00e1p tr\u1ecb li\u1ec7u s\u00e1ng t\u1ea1o. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111ang theo d\u00f5i ch\u1eb7t ch\u1ebd ti\u1ebfn tr\u00ecnh c\u1ee7a Amgen, \u0111\u01b0a ra nhi\u1ec1u quan \u0111i\u1ec3m kh\u00e1c nhau v\u1ec1 s\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh, hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu v\u00e0 tri\u1ec3n v\u1ecdng t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ty. Ph\u00e2n t\u00edch chuy\u00ean s\u00e2u n\u00e0y h\u1ee3p nh\u1ea5t nh\u1eefng hi\u1ec3u bi\u1ebft m\u1edbi nh\u1ea5t t\u1eeb c\u00e1c chuy\u00ean gia trong ng\u00e0nh, cung c\u1ea5p c\u00e1i nh\u00ecn to\u00e0n di\u1ec7n v\u1ec1 v\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng, ph\u00e2n kh\u00fac s\u1ea3n ph\u1ea9m, b\u1ed1i c\u1ea3nh c\u1ea1nh tranh c\u1ee7a Amgen v\u00e0 h\u01a1n th\u1ebf n\u1eefa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hva.group\/en\/wall-street-research-goes-after-amgens-strategic-changes\/\" \/>\n<meta property=\"og:site_name\" content=\"HVA Group\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-02T02:42:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-26T09:24:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"HVA Group\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HVA Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/\"},\"author\":{\"name\":\"HVA Group\",\"@id\":\"https:\/\/hva.group\/#\/schema\/person\/03729d08a6ea1d70c6f95c49510d6da1\"},\"headline\":\"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen\",\"datePublished\":\"2023-12-02T02:42:37+00:00\",\"dateModified\":\"2024-08-26T09:24:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/\"},\"wordCount\":2416,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/hva.group\/#organization\"},\"image\":{\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg\",\"keywords\":[\"Kinh t\u1ebf\",\"T\u00e0i ch\u00ednh\"],\"articleSection\":[\"Tin t\u1ee9c th\u1ecb tr\u01b0\u1eddng\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/\",\"url\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/\",\"name\":\"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen - HVA Group\",\"isPartOf\":{\"@id\":\"https:\/\/hva.group\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg\",\"datePublished\":\"2023-12-02T02:42:37+00:00\",\"dateModified\":\"2024-08-26T09:24:29+00:00\",\"description\":\"Trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m sinh h\u1ecdc ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, Amgen Inc. (NASDAQ: AMGN) \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a Ph\u1ed1 Wall v\u1edbi \u0111\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd, mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 ph\u01b0\u01a1ng ph\u00e1p tr\u1ecb li\u1ec7u s\u00e1ng t\u1ea1o. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111ang theo d\u00f5i ch\u1eb7t ch\u1ebd ti\u1ebfn tr\u00ecnh c\u1ee7a Amgen, \u0111\u01b0a ra nhi\u1ec1u quan \u0111i\u1ec3m kh\u00e1c nhau v\u1ec1 s\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh, hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu v\u00e0 tri\u1ec3n v\u1ecdng t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ty. Ph\u00e2n t\u00edch chuy\u00ean s\u00e2u n\u00e0y h\u1ee3p nh\u1ea5t nh\u1eefng hi\u1ec3u bi\u1ebft m\u1edbi nh\u1ea5t t\u1eeb c\u00e1c chuy\u00ean gia trong ng\u00e0nh, cung c\u1ea5p c\u00e1i nh\u00ecn to\u00e0n di\u1ec7n v\u1ec1 v\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng, ph\u00e2n kh\u00fac s\u1ea3n ph\u1ea9m, b\u1ed1i c\u1ea3nh c\u1ea1nh tranh c\u1ee7a Amgen v\u00e0 h\u01a1n th\u1ebf n\u1eefa.\",\"breadcrumb\":{\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage\",\"url\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg\",\"contentUrl\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg\",\"width\":800,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Trang ch\u1ee7\",\"item\":\"https:\/\/hva.group\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tin t\u1ee9c th\u1ecb tr\u01b0\u1eddng\",\"item\":\"https:\/\/hva.group\/tin-tuc-thi-truong\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/hva.group\/#website\",\"url\":\"https:\/\/hva.group\/\",\"name\":\"HVA Group\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/hva.group\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/hva.group\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/hva.group\/#organization\",\"name\":\"HVA Group\",\"url\":\"https:\/\/hva.group\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hva.group\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/11\/HVA-200-X-200.png\",\"contentUrl\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/11\/HVA-200-X-200.png\",\"width\":200,\"height\":200,\"caption\":\"HVA Group\"},\"image\":{\"@id\":\"https:\/\/hva.group\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/hva.group\/#\/schema\/person\/03729d08a6ea1d70c6f95c49510d6da1\",\"name\":\"HVA Group\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/hva.group\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/09\/Logo-200x200-1-96x96.png\",\"contentUrl\":\"https:\/\/hva.group\/wp-content\/uploads\/2023\/09\/Logo-200x200-1-96x96.png\",\"caption\":\"HVA Group\"},\"description\":\"C\u1ed5 phi\u1ebfu HVA, l\u00e0 l\u1ef1a ch\u1ecdn sinh l\u1eddi b\u1ec1n v\u1eefng trong l\u0129nh v\u1ef1c \u0111\u1ea7u t\u01b0. Cam k\u1ebft \u0111em l\u1ea1i an to\u00e0n v\u00e0 l\u1ee3i \u00edch t\u1ed1i \u0111a cho nh\u00e0 \u0111\u1ea7u t\u01b0 qua c\u00e1c gi\u1ea3i ph\u00e1p \u0111\u1ea7u t\u01b0 hi\u1ec7u qu\u1ea3\",\"url\":\"https:\/\/hva.group\/en\/author\/hvagroup\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Professional Research: Wall Street Digs Into Amgen's Strategic Shifts - HVA Group","description":"Amid the rapidly evolving biopharmaceutical landscape, Amgen Inc. (NASDAQ: AMGN) has captured Wall Street\u2019s attention with its robust pipeline, strategic acquisitions, and innovative therapeutics. Analysts are closely monitoring Amgen\u2019s progress, offering a variety of views on the company\u2019s financial health, stock performance, and future prospects. This in-depth analysis incorporates the latest insights from industry experts, providing a comprehensive look at Amgen\u2019s market position, product segments, competitive landscape, and more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/posts\/3140","og_locale":"en_US","og_type":"article","og_title":"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen","og_description":"Trong b\u1ed1i c\u1ea3nh d\u01b0\u1ee3c ph\u1ea9m sinh h\u1ecdc ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, Amgen Inc. (NASDAQ: AMGN) \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a Ph\u1ed1 Wall v\u1edbi \u0111\u01b0\u1eddng \u1ed1ng m\u1ea1nh m\u1ebd, mua l\u1ea1i chi\u1ebfn l\u01b0\u1ee3c v\u00e0 ph\u01b0\u01a1ng ph\u00e1p tr\u1ecb li\u1ec7u s\u00e1ng t\u1ea1o. C\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111ang theo d\u00f5i ch\u1eb7t ch\u1ebd ti\u1ebfn tr\u00ecnh c\u1ee7a Amgen, \u0111\u01b0a ra nhi\u1ec1u quan \u0111i\u1ec3m kh\u00e1c nhau v\u1ec1 s\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh, hi\u1ec7u su\u1ea5t c\u1ed5 phi\u1ebfu v\u00e0 tri\u1ec3n v\u1ecdng t\u01b0\u01a1ng lai c\u1ee7a c\u00f4ng ty. Ph\u00e2n t\u00edch chuy\u00ean s\u00e2u n\u00e0y h\u1ee3p nh\u1ea5t nh\u1eefng hi\u1ec3u bi\u1ebft m\u1edbi nh\u1ea5t t\u1eeb c\u00e1c chuy\u00ean gia trong ng\u00e0nh, cung c\u1ea5p c\u00e1i nh\u00ecn to\u00e0n di\u1ec7n v\u1ec1 v\u1ecb tr\u00ed th\u1ecb tr\u01b0\u1eddng, ph\u00e2n kh\u00fac s\u1ea3n ph\u1ea9m, b\u1ed1i c\u1ea3nh c\u1ea1nh tranh c\u1ee7a Amgen v\u00e0 h\u01a1n th\u1ebf n\u1eefa.","og_url":"https:\/\/hva.group\/en\/wall-street-research-goes-after-amgens-strategic-changes\/","og_site_name":"HVA Group","article_published_time":"2023-12-02T02:42:37+00:00","article_modified_time":"2024-08-26T09:24:29+00:00","og_image":[{"width":800,"height":500,"url":"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg","type":"image\/jpeg"}],"author":"HVA Group","twitter_card":"summary_large_image","twitter_misc":{"Written by":"HVA Group","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#article","isPartOf":{"@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/"},"author":{"name":"HVA Group","@id":"https:\/\/hva.group\/#\/schema\/person\/03729d08a6ea1d70c6f95c49510d6da1"},"headline":"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen","datePublished":"2023-12-02T02:42:37+00:00","dateModified":"2024-08-26T09:24:29+00:00","mainEntityOfPage":{"@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/"},"wordCount":2416,"commentCount":0,"publisher":{"@id":"https:\/\/hva.group\/#organization"},"image":{"@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage"},"thumbnailUrl":"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg","keywords":["Kinh t\u1ebf","T\u00e0i ch\u00ednh"],"articleSection":["Tin t\u1ee9c th\u1ecb tr\u01b0\u1eddng"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/","url":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/","name":"Professional Research: Wall Street Digs Into Amgen's Strategic Shifts - HVA Group","isPartOf":{"@id":"https:\/\/hva.group\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage"},"image":{"@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage"},"thumbnailUrl":"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg","datePublished":"2023-12-02T02:42:37+00:00","dateModified":"2024-08-26T09:24:29+00:00","description":"Amid the rapidly evolving biopharmaceutical landscape, Amgen Inc. (NASDAQ: AMGN) has captured Wall Street\u2019s attention with its robust pipeline, strategic acquisitions, and innovative therapeutics. Analysts are closely monitoring Amgen\u2019s progress, offering a variety of views on the company\u2019s financial health, stock performance, and future prospects. This in-depth analysis incorporates the latest insights from industry experts, providing a comprehensive look at Amgen\u2019s market position, product segments, competitive landscape, and more.","breadcrumb":{"@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#primaryimage","url":"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg","contentUrl":"https:\/\/hva.group\/wp-content\/uploads\/2023\/12\/Thiet-ke-chua-co-ten-4.jpg","width":800,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/hva.group\/nghien-cuu-chuyen-nghiep-pho-wall-di-sau-vao-nhung-thay-doi-chien-luoc-cua-amgen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Trang ch\u1ee7","item":"https:\/\/hva.group\/"},{"@type":"ListItem","position":2,"name":"Tin t\u1ee9c th\u1ecb tr\u01b0\u1eddng","item":"https:\/\/hva.group\/tin-tuc-thi-truong\/"},{"@type":"ListItem","position":3,"name":"Nghi\u00ean c\u1ee9u chuy\u00ean nghi\u1ec7p: Ph\u1ed1 Wall \u0111i s\u00e2u v\u00e0o nh\u1eefng thay \u0111\u1ed5i chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a Amgen"}]},{"@type":"WebSite","@id":"https:\/\/hva.group\/#website","url":"https:\/\/hva.group\/","name":"HVA Group","description":"","publisher":{"@id":"https:\/\/hva.group\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hva.group\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hva.group\/#organization","name":"HVA Group","url":"https:\/\/hva.group\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hva.group\/#\/schema\/logo\/image\/","url":"https:\/\/hva.group\/wp-content\/uploads\/2023\/11\/HVA-200-X-200.png","contentUrl":"https:\/\/hva.group\/wp-content\/uploads\/2023\/11\/HVA-200-X-200.png","width":200,"height":200,"caption":"HVA Group"},"image":{"@id":"https:\/\/hva.group\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/hva.group\/#\/schema\/person\/03729d08a6ea1d70c6f95c49510d6da1","name":"HVA Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hva.group\/#\/schema\/person\/image\/","url":"https:\/\/hva.group\/wp-content\/uploads\/2023\/09\/Logo-200x200-1-96x96.png","contentUrl":"https:\/\/hva.group\/wp-content\/uploads\/2023\/09\/Logo-200x200-1-96x96.png","caption":"HVA Group"},"description":"HVA shares are a sustainable profitable choice in the investment field. Committed to bringing safety and maximum benefits to investors through effective investment solutions.","url":"https:\/\/hva.group\/en\/author\/hvagroup\/"}]}},"_links":{"self":[{"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/posts\/3140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/comments?post=3140"}],"version-history":[{"count":0,"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/posts\/3140\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/media\/3141"}],"wp:attachment":[{"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/media?parent=3140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/categories?post=3140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hva.group\/en\/wp-json\/wp\/v2\/tags?post=3140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}